Pyranose Biotherapeutics, Inc. is a privately-held, discovery-stage platform company using novel, proprietary technologies to significantly enhance the performance and reduce the manufacturing cost of leading biotherapeutics. Our processes are designed to yield new and improved molecules to address the significant unmet medical needs in serious diseases such as cancer and immune disorders.
By targeting therapeutics with validated mechanisms and established safety and efficacy profiles, development risk is reduced while providing significant differentiation to patients in terms of safety, efficacy, convenience and cost.
Content copyright . pyranosebio.com. All rights reserved.